Prithviraj Bose, MD
Dr. Bose is Associate Professor in the Department of Leukemia at the MD Anderson Cancer Center in Houston.
Articles by Prithviraj Bose, MD
An expert on myelofibrosis comments on promising results from current trials and on the need for useful clinical biomarkers.
Dr. Bose highlights news on MPN featured at the SOHO 2024 Annual Meeting.
New therapies, such as TP-3654, are currently being explored in combination studies.
Prefibrotic myelofibrosis is the focus of “SOHO State of the Art Updates and Next Questions.”
Myelofibrosis, a rare blood cancer, affects four to six per 100,000 individuals in the United States.
Prithviraj Bose, MD, and colleagues presented results of the study during the 2023 ASCO Annual Meeting.
Pacritinib demonstrates consistent efficacy for spleen and symptom response in patients with MF regardless of blood counts.
Experts discuss emerging therapeutic targets, the impact of recently approved agents, and incorporating them into practice.
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.